These results suggested that anti-Fn-IgA and -IgG level were not associated with the progression of the CRC, but anti-Fn-IgA and -IgG level may provide an additional diagnostic value for those patients with CEA- negative or in early stage of CRC. Here, CEACAM5 is linked to colorectal carcinoma.